Proactive Cancer Screening Test

Proactive Cancer Screening Test

Annual health checks most often have cancer screening but sometimes found that the finding those abnormalities only when the cancer has occurred. Which sometimes may not be able to treat.

Early detection for early protection with a new type of cancer screening

EDIM Cancer Screening Test

is a new type of special examination that uses a technique called Epitope Detection In Monocytes from Germany. It is a highly sensitive cancer screening that can be examined from the period before the cancer occurred. This examination relies on the follow -up of the function of the white blood cell named Macrophage, which is responsible for the cancer cell elimination. The amount of protein within the macrophage will change, If the cells in the body have abnormal operation and tend to become cancer cells in the future. In addition, EDIM test can also be used to monitor after cancer treatment.

Properties of EDIM Test

  • Can be checked from cancer stage 0 : This is the most important benefit of this examination. Makes it possible to prevent cancer early and increase the success rate of cancer treatment.
  • High accuracy: This examination is 97.5% sensitivity and 99.53% specificity, therefore has a high reliable results.
  • Cover many types of cancer: It can detect abnormalities of cells that may become many types of cancer. Therefore, it is a cancer screening test for all genders and ages.

Who is it suitable for?

  • People at risk of cancer, such as frequent stress, inadequate rest, drink alcohol, smoke cigarettes, or live in pollution area.
  • People with cancer history in the family.
  • Cancer patients who require close monitoring after treatment.
This website uses cookies to enhance performance and provide you with a better browsing experience. You can read more details at Privacy Policy and Cookies Policy
Compare product
0/4
Remove all
Compare
Powered By MakeWebEasy Logo MakeWebEasy